This forum was the second in a two-part series that looks at racial equity in the drug development system, from investment all the way through access.
It focused on equity in the patent system, clinical trials, health care delivery, and affordability. Watch the recording to learn more about the first part of this conversation.
Watch the video
Senior Vice President, National Equity, Inclusion, and Diversity Strategy and Policy, and Chief Equity, Inclusion, and Diversity Officer, Kaiser Permanente
Society of Cardiac Angiography and Intervention (SCAI) vascular disease committee
Writing fellow, bioethics, Harvard Medical School; fellow, New York Academy of Medicine
|10:30 - 10:45 a.m.||Opening remarks|
|10:45 - 11:20 a.m.||Fireside chat: Author and ethicist Harriet Washington on racial equity in clinical trials and the patent system|
|11:20 - 11:55 a.m.||Fireside chat: Dr. Foluso Fakorede on racial equity in health care delivery and drug affordability|
|11:55 - 12:00 p.m.||Closing remarks|